| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
103,650,000 |
| Market
Cap: |
1.62(B) |
| Last
Volume: |
789,519 |
Avg
Vol: |
1,671,490 |
| 52
Week Range: |
$11.62 - $17.29 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 604 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
152,656 |
276,656 |
406,656 |
4,306,172 |
| Total Sell Value |
$2,459,484 |
$4,152,934 |
$5,994,534 |
$64,305,632 |
| Total People Sold |
5 |
6 |
7 |
13 |
| Total Sell Transactions |
5 |
8 |
11 |
55 |
| End Date |
2024-03-12 |
2023-12-10 |
2023-06-11 |
2022-06-11 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Miller Steve |
VP Development & ManagementOff |
• – – |
2007-04-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
72,960 |
|
- |
|
| Wallace Milton J |
Director |
– • – |
2007-04-02 |
4 |
B |
$3.69 |
$18,450 |
I/I |
5,000 |
295,000 |
2.1 |
- |
|
| Wallace Milton J |
Director |
– • – |
2007-03-28 |
4 |
B |
$4.02 |
$20,100 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| O'keeffe Charles B |
Director |
– • – |
2007-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,944 |
43,776 |
|
- |
|
| Wallace Milton J |
Director |
– • – |
2007-03-09 |
4 |
B |
$4.75 |
$25,907 |
D/D |
5,454 |
290,000 |
2.39 |
- |
|
| Grande Alicia |
Chief Accounting OfficerOffice |
• – – |
2007-01-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,000 |
|
- |
|
| O'keeffe Charles B |
Director |
– • – |
2006-10-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,832 |
|
- |
|
| Mcenany Patrick J |
President and Chief ExecutiveO |
• • • |
2006-10-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
145,922 |
|
- |
|
| Mcenany Patrick J |
President and Chief ExecutiveO |
• • • |
2006-10-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,074,210 |
|
- |
|
| Tierney David S |
Director |
– • – |
2006-10-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
182,402 |
|
- |
|
| Wallace Milton J |
Director |
– • – |
2006-10-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
29,184 |
|
- |
|
| Wallace Milton J |
Director |
– • – |
2006-10-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
284,548 |
|
- |
|
| Huckel Hubert E Md |
Director |
– • • |
2006-10-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,149,135 |
|
- |
|
| Coelho Philip H |
Director |
– • – |
2006-10-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
218,883 |
|
- |
|
439 Records found
|
|
Page 18 of 18 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.14 (0.89%) 
